Related Experiment Video

Updated: Jul 15, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Metabolic targeting as an anticancer strategy: dawn of a new era?

James G Pan1, Tak W Mak

  • 1Campbell Family Institute for Breast Cancer Research, University Health Network TMDT East Tower, MaRs Centre, Toronto, ON, Canada. jpan@uhnres.utoronto.ca

Science'S STKE : Signal Transduction Knowledge Environment
|April 12, 2007
PubMed

Insights

Dichloroacetate (DCA) targets cancer cell metabolism by inhibiting pyruvate dehydrogenase kinase (PDK). This reactivates mitochondrial respiration, selectively killing tumor cells and suppressing cancer growth in mice.

Area of Science:

  • Biochemistry
  • Cancer Biology
  • Mitochondrial Medicine

Background:

  • Tumor cells exhibit mitochondrial defects, leading to aerobic glycolysis (Warburg effect) for ATP production.
  • Pyruvate dehydrogenase kinase (PDK) inhibits pyruvate dehydrogenase (PDH), blocking pyruvate entry into the TCA cycle.

Purpose of the Study:

  • To investigate the therapeutic potential of dichloroacetate (DCA) in cancer treatment.
  • To explore DCA's effect on tumor cell metabolism and growth.

Main Methods:

  • Treatment of tumor-bearing mice with dichloroacetate (DCA).
  • Analysis of mitochondrial respiration and tumor cell viability.

Main Results:

  • DCA inhibits PDK, reactivating mitochondrial respiration in tumor cells.
  • DCA treatment led to selective killing of tumor cells and suppressed cancer growth in mice.

Conclusions:

  • Targeting tumor cell metabolism via DCA offers a promising therapeutic strategy.
  • DCA's ability to reverse the Warburg effect presents new avenues for cancer intervention.

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.